MX7718E - PROCEDURE FOR PREPARING AN ANTI-MAREK POULTRY VACCINE - Google Patents
PROCEDURE FOR PREPARING AN ANTI-MAREK POULTRY VACCINEInfo
- Publication number
- MX7718E MX7718E MX851025U MX102585U MX7718E MX 7718 E MX7718 E MX 7718E MX 851025 U MX851025 U MX 851025U MX 102585 U MX102585 U MX 102585U MX 7718 E MX7718 E MX 7718E
- Authority
- MX
- Mexico
- Prior art keywords
- marek
- disease
- virus
- mdv
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention relates to a highly immunogenic virus preparation derived by attenuation employing serial passages in avian cell cultures and six plaque purification steps from a Marek's disease virus strain, belonging to Avian Herpesvirus serotype-1. The original virus strain MDV CVI-988 was recovered from a healthy chicken (Avian Disease 16:108-125,1972).The live purified Marek's disease vaccine so obtained is innocuous for specific pathogen free Rhode Island Red chickens which are highly susceptible for development of Marek's disease tumours. The monovalent virus preparation, according to the invention, demonstrated in comparison with Marek's disease vaccines based on the same strain, currently in use at a lower cell passage level, an improved protective efficacy against challenge infection by two representatives of virulent Marek's disease virus.The monovalent virus preparation, according to the invention, provided significantly better protection than current MDV CVI-988 vaccine to challenge infection with a representative of the group of newly emerging very virulent strains of Marek's disease virus, MDV RB/1B. The monovalent virus strains of Marek's disease virus, MDV RB/1B. The monovalent virus preparation, according to the invention, provided significantly better protection than is HVT FC126 vaccine to challenge infection with another representative of the group of very virulent MD viruses, MDV Tun.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8401120A NL8401120A (en) | 1984-04-09 | 1984-04-09 | VIRUS PREPARATION FOR VACCINATION AGAINST MAREK'S DISEASE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX7718E true MX7718E (en) | 1990-10-10 |
Family
ID=19843774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX851025U MX7718E (en) | 1984-04-09 | 1985-04-08 | PROCEDURE FOR PREPARING AN ANTI-MAREK POULTRY VACCINE |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4673572A (en) |
| EP (1) | EP0159743B1 (en) |
| JP (1) | JPS6123A (en) |
| AT (1) | ATE56364T1 (en) |
| AU (1) | AU574164B2 (en) |
| CA (1) | CA1251397A (en) |
| DD (1) | DD232822A5 (en) |
| DE (1) | DE3579617D1 (en) |
| ES (1) | ES8605680A1 (en) |
| HU (1) | HU194496B (en) |
| IL (1) | IL74809A (en) |
| IN (1) | IN163229B (en) |
| MX (1) | MX7718E (en) |
| NL (1) | NL8401120A (en) |
| WO (1) | WO1985004588A1 (en) |
| YU (1) | YU44687B (en) |
| ZA (1) | ZA852564B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4456101A (en) * | 1980-11-08 | 1984-06-26 | Honda Giken Kogyo Kabushiki Kaisha | Vehicular brake operating system |
| JP2508625B2 (en) * | 1985-08-30 | 1996-06-19 | ソニー株式会社 | Semiconductor laser |
| FR2598596B1 (en) * | 1986-05-15 | 1990-10-19 | Sanofi Elf Bio Ind | MILK PROCESSING PROCESS FOR OBTAINING CHEESE |
| US5849299A (en) * | 1991-06-28 | 1998-12-15 | The United States Of America As Represented By The Secretary Of Agriculture | Attenuated revertant serotype 1 marek's disease vaccine |
| WO1993023078A1 (en) * | 1992-05-19 | 1993-11-25 | Viktoria Alexeevna Lukina | Vaccine for prophylaxis of marek disease of birds and method of its preparation |
| IL114501A (en) * | 1994-07-14 | 1999-08-17 | Akzo Nobel Nv | Marek's disease virus vaccine |
| EP0703294A1 (en) * | 1994-07-14 | 1996-03-27 | Akzo Nobel N.V. | Marek's disease virus vaccine |
| EP0748867A1 (en) * | 1995-06-12 | 1996-12-18 | Duphar International Research B.V | Marek's disease vaccine |
| US5989805A (en) * | 1995-10-27 | 1999-11-23 | Board Of Trustees Operating Michigan State University | Immortal avian cell line to grow avian and animal viruses to produce vaccines |
| WO1997046103A1 (en) * | 1996-06-04 | 1997-12-11 | University Of Georgia Research Foundation, Inc. | Modified live avian polyomavirus vaccine in psittacine birds |
| EP1038952A3 (en) * | 1998-12-09 | 2001-06-27 | Pfizer Products Inc. | Processes for preparation of Marek's Disease Virus using continuous avian cell lines |
| AP2014007955A0 (en) | 2012-03-22 | 2014-09-30 | Merial Ltd | Modified marek's disease virus, and vaccines made therefrom |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1292803A (en) * | 1968-11-18 | 1972-10-11 | Nat Res Dev | Improvements relating to the production of antigens |
| US3642574A (en) * | 1970-04-29 | 1972-02-15 | Us Agriculture | Method for producing vaccine for immunization of poultry against marek{3 s disease |
| US3783098A (en) * | 1971-08-10 | 1974-01-01 | Cornell Res Foundation Inc | Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same |
| US4160024A (en) * | 1978-05-01 | 1979-07-03 | Cornell Research Foundation, Inc. | Marek's disease vaccine |
-
1984
- 1984-04-09 NL NL8401120A patent/NL8401120A/en not_active Application Discontinuation
-
1985
- 1985-03-25 AT AT85200461T patent/ATE56364T1/en not_active IP Right Cessation
- 1985-03-25 EP EP85200461A patent/EP0159743B1/en not_active Expired - Lifetime
- 1985-03-25 DE DE8585200461T patent/DE3579617D1/en not_active Expired - Lifetime
- 1985-03-27 WO PCT/NL1985/000014 patent/WO1985004588A1/en unknown
- 1985-03-27 AU AU41561/85A patent/AU574164B2/en not_active Ceased
- 1985-03-27 HU HU851448A patent/HU194496B/en not_active IP Right Cessation
- 1985-03-28 IN IN234/CAL/85A patent/IN163229B/en unknown
- 1985-04-03 IL IL74809A patent/IL74809A/en not_active IP Right Cessation
- 1985-04-03 ES ES541930A patent/ES8605680A1/en not_active Expired
- 1985-04-04 ZA ZA852564A patent/ZA852564B/en unknown
- 1985-04-05 US US06/720,176 patent/US4673572A/en not_active Expired - Lifetime
- 1985-04-08 MX MX851025U patent/MX7718E/en unknown
- 1985-04-08 DD DD85274954A patent/DD232822A5/en not_active IP Right Cessation
- 1985-04-09 YU YU599/85A patent/YU44687B/en unknown
- 1985-04-09 JP JP60075246A patent/JPS6123A/en active Granted
- 1985-04-09 CA CA000478672A patent/CA1251397A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IL74809A (en) | 1990-09-17 |
| EP0159743A1 (en) | 1985-10-30 |
| IL74809A0 (en) | 1985-07-31 |
| YU59985A (en) | 1988-06-30 |
| HUT38542A (en) | 1986-06-30 |
| IN163229B (en) | 1988-08-27 |
| NL8401120A (en) | 1985-11-01 |
| YU44687B (en) | 1990-12-31 |
| ATE56364T1 (en) | 1990-09-15 |
| ES541930A0 (en) | 1986-04-16 |
| ZA852564B (en) | 1985-11-27 |
| DE3579617D1 (en) | 1990-10-18 |
| JPS6123A (en) | 1986-01-06 |
| ES8605680A1 (en) | 1986-04-16 |
| CA1251397A (en) | 1989-03-21 |
| EP0159743B1 (en) | 1990-09-12 |
| WO1985004588A1 (en) | 1985-10-24 |
| US4673572A (en) | 1987-06-16 |
| AU4156185A (en) | 1985-11-01 |
| JPH0317808B2 (en) | 1991-03-11 |
| DD232822A5 (en) | 1986-02-12 |
| HU194496B (en) | 1988-02-29 |
| AU574164B2 (en) | 1988-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX7718E (en) | PROCEDURE FOR PREPARING AN ANTI-MAREK POULTRY VACCINE | |
| Cubillos et al. | Characterisation of strains of infectious bronchitis virus isolated in Chile | |
| EP0125245B1 (en) | Propagation of hemorrhagic enteritis virus in a turkey cell line | |
| US3674861A (en) | Live attenuated marek{40 s disease virus vaccine for poultry | |
| ALLEN et al. | Role of coexpression of IL-2 and herpes simplex virus proteins in recombinant vaccinia virus vectors on levels of induced immunity | |
| US4895717A (en) | Revertant serotype 1 Marek's disease vaccine | |
| CA1292689C (en) | Live vaccine for contagious disease of chickens | |
| KR0127116B1 (en) | Infections brusal disease vaccine | |
| US5686287A (en) | Marek's disease virus vaccine | |
| CA1339963C (en) | Live combination vaccine containing infectious bronchitis virus | |
| EP0496135A2 (en) | Cell free marek's disease virus vaccine | |
| US4895718A (en) | Serotype 2 Marek's disease vaccine | |
| Powell | Protection against the JMV Marek's disease‐derived transplantable tumour by Marek's disease virus‐specific antigens | |
| Carmichael et al. | Small-plaque variant of canine herpesvirus with reduced pathogenicity for newborn pups | |
| Morein et al. | Vaccination against herpesvirus, fiction or reality | |
| US4213965A (en) | Small-plaque variant canine herpesvirus vaccine | |
| US5565202A (en) | Low enhancement serotype 2 vaccine for marek's disease | |
| CA2112225C (en) | Attenuated revertant serotype 1 marek's disease vaccine | |
| Thompson et al. | Cytotoxic activity of cells recovered from the respiratory tracts of chickens inoculated with infectious bronchitis virus | |
| EP0703294A1 (en) | Marek's disease virus vaccine | |
| El‐Zein et al. | Preparation and testing of a goat pox vaccine from a pathogenic field isolate attenuated in cell culture | |
| JP3040157B2 (en) | Attenuated canine parvovirus vaccine containing canine parvovirus (CPV) and prevention of CPV infection in canines | |
| CA1289881C (en) | Vaccine against herpes simplex | |
| SU1707075A1 (en) | Strain of virus of marekъs disease for production of vaccine against marekъs disease | |
| Shibuta | Production of pertussis toxin mutant protein by Bordetella pertussis variant for use in whooping cough vaccine preparation |